
Anlon Healthcare
Mainboard₹14,924 / 164 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 29 Aug 2025,06:45:00 PM |
| QIBs | 1.07 |
| NII | Bids above ₹10L: 7.56 times Bids below ₹10L: 16.69 times NII Total: 10.61 |
| Retail | 47.30 times |
| Total | 7.13 times |
Anlon Healthcare IPO Details
The Anlon Healthcare IPO price band is set between ₹86-91 per equity share, with a face value of ₹10 per share. The issue is managed by Kfin Technologies Ltd, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 26 Aug, 2025 and closes on 29 Aug, 2025. Investors can check the allotment status on 1 Sep, 2025, while the listing date is tentatively scheduled for 3 Sep, 2025.
The total issue size is 1,33,00,000 shares, aggregating up to ₹121.03 Cr. Stay tuned for the latest Anlon Healthcare IPO review and GMP updates.
Anlon Healthcare IPO Review, Rating & Analysis
Anlon Healthcare IPO Review
NO REVIEWAnlon Healthcare IPO Rating
Anlon Healthcare IPO Highlights
IPO Date
Aug 26, 2025 - Aug 29, 2025
Listing Date
3 Sep, 2025
Face Value
₹10 Per Equity Share
Price Band
₹86-91 per equity share
Lot Size
164 Shares
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Anlon Healthcare IPO Lot Size
The minimum market lot for Anlon Healthcare IPO is 164 shares with an application amount of ₹14,924. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 164 | ₹14,924 |
| Retail (Max) | 13 | 2132 | ₹1,94,012 |
| S-HNI (Min) | 14 | 2296 | ₹2,08,936 |
| S-HNI (Max) | 67 | 10988 | ₹9,99,908 |
| B-HNI (Min) | 68 | 11152 | ₹10,14,832 |
Anlon Healthcare IPO Timeline
Issue Price
₹86-91 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LtdLead Manager
Interactive Financial Services LtdIssue Size
1,33,00,000 shares(aggregating up to ₹121.03 Cr)Anlon Healthcare IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 25 | 181.30 | 120.46 | 20.52 | 80.42 | 40.57 | 58.35 |
| 31 Mar 24 | 128.00 | 66.69 | 9.66 | 21.03 | 5.03 | 74.56 |
| 31 Mar 23 | 111.55 | 113.12 | 5.82 | 7.37 | -4.63 | 66.39 |
All values are in ₹ Cr.
Anlon Healthcare IPO Valuations
EPS Pre IPO
₹5.15/-EPS Post IPO
₹3.86/-PE Pre IPO
17.67PE Post IPO
23.57ROE
40.45%ROCE
21.93%Debt Equity
0.73RoNW
25.51%PAT Margin
17.06%Price to Book Value
4.51Promoters & Share Holding
Promoter(s) Name
- Punitkumar R. rasadia
- Meet Atulkumar Vachhani
- Mamata punitkumar Rasadia
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 70.26% | N/A% |
About Company
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing firm involved in the production of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The firm produces high-purity pharmaceutical intermediates (for API synthesis) and active pharmaceutical ingredients (utilized in formulations for pharmaceuticals, nutraceuticals, personal care, and animal health products).The firm deals in pharma intermediates, APIs for drugs, nutraceuticals, personal care, and veterinary products, all of which are produced to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.Besides producing Pharma Intermediates and APIs to international specifications, the firm now provides contract manufacturing of complex chemicals beyond purity levels and lowering impurities to suit particular customers' requirements.
The firm has been approved by ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs in terms of Drug Master File (DMF). The firm has submitted 21 DMFs to worldwide authorities and is submitting for Ketoprofen and Dexketoprofen Trometamol approvals.65 commercial products, 28 pilot-scale products, and 49 lab-scale products are part of the firm's portfolio.
The firm maintains product quality through thorough testing, analysis, and process optimization. Backed by four laboratories, the 34-strong team, which comprises 24 science graduates, guarantees that products meet customer and industry requirements.
Anlon Healthcare IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 99,75,000 | 19,95,000 13,30,000 6,65,000 | 13,30,000 | 1,33,00,000 |
Day 1 -26-08-25 05:00 PM | 0.91 x | 0.71 0.48 x 1.17 x | 8.99 x | 1.69 x |
Day 2 -28-08-25 05:00 PM | 1.01 x | 2.09 1.38 x 3.51 x | 22.32 x | 3.30 x |
Day 3 -28-08-25 05:00 PM | 1.07 x | 10.60 7.56 x 16.66 x | 47.04 x | 7.10 x |
Retail:42.0x
BHNI:1.5x
SHNI:16.0x times
Company Contact Details
Anlon Healthcare
101/102, Silvercoin Complex, Opp.Crystal Mall,Kalawad Road Rajkot, Gujarat, 360005Registrar Contact Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: ahl.ipo@kfintech.com
Frequently Asked Questions about Anlon Healthcare IPO
When will Anlon Healthcare IPO open for subscription?
The Anlon Healthcare IPO opens on 26 Aug, 2025 and closes on 29 Aug, 2025.
What is the investors portion for Anlon Healthcare IPO?
The investors' portion for QIB is 1.07 x, NII is 7.56 x, and Retail is 47.04 x.
How to apply for Anlon Healthcare IPO?
You can apply for Anlon Healthcare IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Anlon Healthcare IPO?
The issue size of Anlon Healthcare IPO is approx ₹1,33,00,000 shares(aggregating up to ₹121.03 Cr) crores.
What is the price band of Anlon Healthcare IPO?
The price band for Anlon Healthcare IPO is ₹86 to ₹91 per equity share.
What is the lot size of Anlon Healthcare IPO?
The minimum bid (lot size) for Anlon Healthcare IPO is N/A shares with an investment of approx ₹14,924 .
What is the allotment date of Anlon Healthcare IPO?
The allotment date for Anlon Healthcare IPO is 1 Sep, 2025.
What is the listing date of Anlon Healthcare IPO?
The listing date for Anlon Healthcare IPO is expected to be 3 Sep, 2025.
What is the GMP of Anlon Healthcare IPO?
The latest Grey Market Premium (GMP) for Anlon Healthcare IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.
